A New Molecular Marker For Prostate Cancer

LOS ANGELES, June, 16, 1998 -- A new molecular marker can be used to better predict tumor progression in men with prostate cancer, the second-leading cause of male cancer deaths in the United States. Researchers at the USC/Norris Comprehensive Cancer Center report the new findings from a study of 96 men with localized disease in the June 17 issue of the Journal of the National Cancer Institute. The team found that patients with tumors expressing abnormally low levels of a protein important in regulating cell division faced a significantly higher risk of disease recurrence and death than patients with tumors expressing high levels of the protein.

"Physicians may be able to use this tumor marker to identify prostate cancer patients most likely to harbor dangerous, life-threatening tumors," says Richard J. Cote, M.D., who led the study team. Cote is an associate professor of pathology and urology at the USC/Norris Cancer Center.

"In addition, the marker can help doctors make better decisions about treatment, ensuring that men most likely to develop metastatic disease undergo aggressive therapies. It will also help identify men who can avoid the most intensive and expensive treatments," he says. The American Cancer Society estimates that this year 184,500 American men will be diagnosed with prostate cancer and that some 42,000 men will die of the disease. With one of the highest incidences of all cancers, it is the second-leading cause of cancer deaths in men. Gauging how aggressive prostate tumors are -- and thus how aggressive treatment should be -- has created a quandary for physicians and men diagnosed with early prostate cancer.

In the last decade, the widespread use of the prostate specific antigen (PSA) test has allowed the detection of many more cases of early prostate cancer than previously possible. Yet, scientists believe that many of the localized tumors identified by the PSA screen are so slow-growing that men are more likely to d

Contact: Eva Emerson
University of Southern California

Page: 1 2 3

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Molecular staples shape a cancer killer
5. Molecular motor myosin VI moves hand over hand, researchers say
6. Molecular therapeutics advance fight against brain cancer
7. Molecular motor shuttles key protein in response to light
8. Molecular traffic cop directs cellular signals
9. Molecular marker predicts success of breast cancer treatment
10. Molecular image of genotoxin reveals how bacteria damage human DNA
11. Molecular mechanism found that may improve ability of stem cells to fight disease

Post Your Comments:
TAG: New Molecular Marker For Prostate Cancer

(Date:9/10/2015)... 10, 2015 Report Details ... Selling Opportunities and Revenue Prospects to Help You ... biologics, especially new drug classes? Get the latest ... with exclusive market data and industry knowledge, benefitting ... results, opportunities and sales predictions. Visiongain,s new ...
(Date:9/8/2015)... Sept. 8, 2015   TREW Marketing and ... survey, Smart Marketing for Engineers TM : Content ... professionals reveals insightful findings about engineers, preferences for online ... content engineers most value and trust, and where they ... targeting technical audiences grapple with how to best implement ...
(Date:9/1/2015)... Sept. 1, 2015  Automation and pre-processing are ... passenger screening. This is the first step toward ... will become unintrusive. An assortment of portal scanners, ... background investigations will transform the passenger screening process. ... Global Airport Passenger Screening Market ( ...
Breaking Biology News(10 mins):
(Date:10/8/2015)...  Today the Wyss Institute for Biologically Inspired Engineering ... company Opsonix Inc. The announcement follows a ... Technology Development (OTD) and Opsonix Inc. enabling the ... use. --> --> ... every year in the U.S. — more than prostate ...
(Date:10/7/2015)... , October 8, 2015 ... Medical biotechnology accounts for largest bioinformatics ... bioinformatics in drug discovery and development process ... http://www.marketreportshub.com/bioinformatics-industry-research-2020-marketsandmarkets.html . --> ... On the basis of applications, the bioinformatics ...
(Date:10/7/2015)... , Oct. 7, 2015  ContraVir Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization of targeted ... public offering of 5,000,000 shares of its common stock ... the Company,s common stock at a fixed combined price ... stock and warrants will be issued separately.  The warrants ...
(Date:10/7/2015)... ... October 07, 2015 , ... ... titled Smart Nanostructured Coatings to provide a comprehensive overview of the innovations in ... webinar at http://bit.do/smart-coatings . This webinar will be given by Professor Roberto ...
Breaking Biology Technology:
Cached News: